首页
订购/客服:400-666-5481

Zibotentan (ZD4054)

    
98.10%

Zibotentan (ZD4054)

源叶(MedMol)
S80492 一键复制产品信息
186497-07-4
C19H16N6O4S
424.43
N-(3-甲氧基-5-甲基-2-吡嗪基)-2-[4-(1,3,4-恶二唑-2-基)苯基]-3-吡啶磺酰胺;Zibotentan; Zd 4054; ZD4054,Zibotentan;
货号 规格 价格 上海 北京 珠海 重庆 武汉 购买数量
S80492-5mg买3赠1
98.10%

¥552.00

7 - - - -
S80492-10mg买3赠1
98.10%

¥930.00

6 - - - -
S80492-50mg买3赠1
98.10%

¥3410.00

2 - - - -
产品介绍 参考文献 质检证书(COA) 摩尔浓度计算器 相关产品
产品描述: Zibotentan (ZD4054) is a potent, selective and orally active endothelin A (ETA) receptor antagonist with a Ki of 13 nM. Zibotentan has no inhibitory effect on ETB. Zibotentan has anticancer effects and can be used for castration-resistant prostate cancer (CRPC) research
靶点: ETA:13 nM (Ki);Apoptosis;EndothelinReceptor
体内研究: Zibotentan (10 mg/kg; intraperitoneal injection; daily; for 21 days) treatment significantly inhibits tumor growth in mice. And Zibotentan treatment increases E-cadherin expression
参考文献: 1. C D Morris, et al. Specific inhibition of the endothelin A receptor with ZD4054: clinical and pre-clinical evidence. Br J Cancer. 2005 Jun 20;92(12):2148-52. 2. Laura Rosanò, et al. Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin Cancer Res. 2011 Apr 15;17(8):2350-60. 3. Laura Rosanò, et al. ZD4054, a specific antagonist of the endothelin A receptor, inhibits tumor growth and enhances paclitaxel activity in human ovarian carcinoma in vitro and in vivo. Mol Cancer Ther. 2007 Jul;6(7):2003-11.
溶解性: Soluble  in  DMSO
保存条件: -20℃
配置溶液浓度参考:
1mg 5mg 10mg
1 mM 2.356 ml 11.781 ml 23.561 ml
5 mM 0.471 ml 2.356 ml 4.712 ml
10 mM 0.236 ml 1.178 ml 2.356 ml
50 mM 0.047 ml 0.236 ml 0.471 ml
注意: 部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。

参考文献

质检证书(COA)

如何获取质检证书(COA)?
请输入货号和一个与之匹配的批号。
例如:
批号:JS298415 货号:S20001-25g
在货品标签上如何找到货号和批号?

摩尔浓度计算器

质量 (mg) = 浓度 (mM) x 体积 (mL) x 分子摩尔量 (g/mol)

=
×
×